Literature DB >> 1736493

Urolithiasis, inhibitors and promoters.

F Grases1, A Conte.   

Abstract

The aim of this work is to evaluate the role and importance of inhibitors and promoters in urolithiasis. Carrying in mind theoretical considerations, we conclude that in urolithogenic processes, inhibitors and promoters could only play a decisive role in the "idiopathic" oxalocalcic urolithiasis. We classify the "idiopathic" oxalocalcic stone-formers into three main groups, considering inhibitory and promoting factors. It is shown that such classification is in good agreement with the clinical results observed in a group of 88 "idiopathic" oxalocalcic stone-formers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736493     DOI: 10.1007/bf00294344

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  6 in total

1.  On the relation between citrate and calcium in normal and stone-former subjects.

Authors:  A Conte; P Roca; M Gianotti; F Grases
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.

Authors:  A Conte; P Roca; C Genestar; F Grases
Journal:  Nephron       Date:  1989       Impact factor: 2.847

3.  Study of factors affecting calcium oxalate crystalline aggregation.

Authors:  F Grases; A Costa-Bauzá
Journal:  Br J Urol       Date:  1990-09

4.  Urolithiasis inhibitors and calculus nucleation.

Authors:  F Grases; J J Gil; A Conte
Journal:  Urol Res       Date:  1989

5.  The relation between orthophosphate and pyrophosphate in normal subjects and in patients with urolithiasis.

Authors:  A Conte; P Roca; C Genestar; F Grases
Journal:  Urol Res       Date:  1989

6.  Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.

Authors:  F Grases; C Genestar; A Conte; P March; A Costa-Bauzá
Journal:  Br J Urol       Date:  1989-09
  6 in total
  5 in total

1.  In vitro crystallisation systems for the study of urinary stone formation.

Authors:  W Achilles
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Epidemiology of urinary stone disease in the Balearic Islands Community.

Authors:  F Grases; A Conte; J G March; C Genestar; A Costa-Bauzá; M Martin; R Vallescar
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

3.  Mechanisms of Stone Formation.

Authors:  Vishal N Ratkalkar; Jack G Kleinman
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

4.  Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation?

Authors:  H G Tiselius; L Larsson
Journal:  Urol Res       Date:  1993-05

5.  Urolithiasis and phytotherapy.

Authors:  F Grases; G Melero; A Costa-Bauzá; R Prieto; J G March
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.